Advertisement

Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients

Published:August 07, 2013DOI:https://doi.org/10.1016/j.jhep.2013.07.037

      Background & Aims

      Unhealthy food intake, specifically fructose, has been associated with metabolic alterations and with the severity of liver fibrosis in patients with non-alcoholic fatty liver disease. In a cohort of patients with genotype 1 chronic hepatitis C (G1 CHC), we tested the association of fructose intake with the severity of liver histology.

      Methods

      Anthropometric and metabolic factors, including waist circumference (WC), waist-to-hip ratio (WHR), dorso-cervical lipohypertrophy and HOMA were assessed in 147 consecutive biopsy-proven G1 CHC patients. Food intake, namely industrial and fruit fructose, was investigated by a three-day structured interview and a computed database.
      All biopsies were scored by an experienced pathologist for staging and grading (Scheuer classification), and graded for steatosis, which was considered moderate-severe if ⩾20%. Features of non-alcoholic steatohepatitis (NASH) in CHC were also assessed (Bedossa classification).

      Results

      Mean daily intake of total, industrial and fruit fructose was 18.0 ± 8.7 g, 6.0 ± 4.7 g, and 11.9 ± 7.2 g, respectively. Intake of industrial, not fruit fructose, was independently associated with higher WHR (p = 0.02) and hypercaloric diet (p <0.001). CHC patients with severe liver fibrosis (⩾F3) reported a significantly higher intake of total (20.8 ± 10.2 vs. 17.2 ± 8.1 g/day; p = 0.04) and industrial fructose (7.8 ± 6.0 vs. 5.5 ± 4.2; p = 0.01), not fruit fructose (12.9 ± 8.0 vs. 11.6 ± 7.0; p= 0.34). Multivariate logistic regression analysis showed that older age (OR 1.048, 95% CI 1.004–1.094, p = 0.03), severe necroinflammatory activity (OR 3.325, 95% CI 1.347–8.209, p= 0.009), moderate-severe steatosis (OR 2.421, 95% CI 1.017–6.415, p= 0.04), and industrial fructose intake (OR 1.147, 95% CI 1.047–1.257, p= 0.003) were independently linked to severe fibrosis. No association was found between fructose intake and liver necroinflammatory activity, steatosis, and the features of NASH.

      Conclusions

      The daily intake of industrial, not fruit fructose is a risk factor for metabolic alterations and the severity of liver fibrosis in patients with G1 CHC.

      Keywords

      Abbreviations:

      HCV (hepatitis C virus), G1 (genotype 1), CHC (chronic hepatitis C), WC (waist circumference), DCL (dorso-cervical lipohypertrophy), WHR (waist-to-hip ratio)

      Linked Article

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Hepatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Herzer K.
        • Sprinzl M.F.
        • Galle P.R.
        Hepatitis viruses: live and let die.
        Liver Int. 2007; 27: 293-301
        • Poynard T.
        • Yuen M.F.
        • Ratziu V.
        • Lai C.L.
        Viral Hepatitis C.
        Lancet. 2003; 362: 2095-2100
        • Romero-Gómez M.
        • Del Mar Viloria M.
        • Andrade R.J.
        • Salmerón J.
        • Diago M.
        • Fernández-Rodríguez C.M.
        • et al.
        Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.
        Gastroenterology. 2005; 128: 636-641
        • Petta S.
        • Cammà C.
        • Di Marco V.
        • Cabibi D.
        • Ciminnisi S.
        • Caldarella R.
        • et al.
        Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.
        Antivir Ther. 2009; 14: 631-639
        • Villa E.
        • Karampatou A.
        • Cammà C.
        • Di Leo A.
        • Luongo M.
        • Ferrari A.
        • et al.
        Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C.
        Gastroenterology. 2011; 140: 818-829
        • Petta S.
        • Ferraro D.
        • Cammà C.
        • Cabibi D.
        • Di Cristina A.
        • Di Marco V.
        • et al.
        Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C.
        Antivir Ther. 2012; 17: 823-831
        • Petta S.
        • Cammà C.
        • Scazzone C.
        • Tripodo C.
        • Di Marco V.
        • Bono A.
        • et al.
        Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C.
        Hepatology. 2010; 51: 1158-1167
        • Torres D.M.
        • Harrison S.A.
        Diagnosis and therapy of nonalcoholic steatohepatitis.
        Gastroenterology. 2008; 134: 1682-1698
        • Tetri L.H.
        • Basaranoglu M.
        • Brunt E.M.
        • Yerian L.M.
        • Neuschwander-Tetri B.A.
        Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent.
        Am J Physiol Gastrointest Liver Physiol. 2008; 295: G987-G995
        • Aeberli I.
        • Hochuli M.
        • Gerber P.A.
        • Sze L.
        • Murer S.B.
        • Tappy L.
        • et al.
        Moderate amounts of fructose consumption impair insulin sensitivity in healthy young men: a randomized controlled trial.
        Diabetes Care. 2012; ([Epub ahead of print])
        • de Ruyter J.C.
        • Olthof M.R.
        • Seidell J.C.
        • Katan M.B.
        A trial of sugar-free or sugar-sweetened beverages and body weight in children.
        N Engl J Med. 2012; 367: 1397-1406
        • Ebbeling C.B.
        • Feldman H.A.
        • Chomitz V.R.
        • et al.
        A randomized trial of sugar-sweetened beverages and adolescent body weight.
        N Engl J Med. 2012; 367: 1407-1416
        • Qi Q.
        • Chu A.Y.
        • Kang J.H.
        • et al.
        Sugar-sweetened beverages and genetic risk of obesity.
        N Engl J Med. 2012; 367: 1387-1396
        • Abdelmalek M.F.
        • Suzuki A.
        • Guy C.
        • Unalp-Arida A.
        • Colvin R.
        • Johnson R.J.
        • et al.
        Nonalcoholic Steatohepatitis Clinical Research Network. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease.
        Hepatology. 2010; 51: 1961-1971
        • Tyson G.L.
        • Richardson P.A.
        • White D.L.
        • Kuzniarek J.
        • Ramsey D.J.
        • Tavakoli-Tabasi S.
        • et al.
        Dietary fructose intake and severity of liver disease in hepatitis C virus-infected patients.
        J Clin Gastroenterol. 2013; ([Epub ahead of print] PubMed PMID: 23426443)
        • American Diabetes Association
        Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. American Diabetes Association: Clinical Practice Recommendations 2000 Committee Report.
        Diabetes Care. 2000; 2000: S4-S19
        • Matthews D.R.
        • Hosker J.P.
        • Rudenski A.S.
        • Naylor B.A.
        • Treacher D.F.
        • Turner R.C.
        Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
        Diabetologia. 1985; 28: 412-419
        • Ikeda Y.
        • Suehiro T.
        • Nakamura T.
        • Kumon Y.
        • Hashimoto K.
        Clinical significance of the insulin resistance index as assessed by homeostasis model assessment.
        Endocr J. 2001; 48: 81-86
        • Colloredo G.
        • Guido M.
        • Sonzogni A.
        • Leandro G.
        Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease.
        J Hepatol. 2003; 39: 239-244
        • Scheuer P.J.
        Classification of chronic viral hepatitis: a need for reassessment.
        J Hepatol. 1991; 13: 372-374
        • Bedossa P.
        • Moucari R.
        • Chelbi E.
        • Asselah T.
        • Paradis V.
        • Vidaud M.
        • et al.
        Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective study.
        Hepatology. 2007 Aug; 46: 380-387
        • Harrell Jr., F.E.
        • Lee K.L.
        • Mark D.B.
        Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.
        Stat Med. 1996; 15: 361-387
        • Concato J.
        • Feinstein A.R.
        • Holford T.R.
        The risk of determining risk with multivariable models.
        Ann Intern Med. 1993; 118: 201-210
      1. SAS Technical Report, SAS/STAT software: changes and enhancement, Release 6.07. Cary, NC: SAS Institute, Inc.; 1992.

        • Zelber-Sagi S.
        • Ratziu V.
        • Oren R.
        Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence.
        World J Gastroenterol. 2011; 17: 3377-3389
        • Cozma A.I.
        • Sievenpiper J.L.
        • de Souza R.J.
        • Chiavaroli L.
        • Ha V.
        • Wang D.D.
        • et al.
        Effect of fructose on glycemic control in diabetes: a systematic review and meta-analysis of controlled feeding trials.
        Diabetes Care. 2012; 35: 1611-1620
        • Wang D.D.
        • Sievenpiper J.L.
        • de Souza R.J.
        • Chiavaroli L.
        • Ha V.
        • Cozma A.I.
        • et al.
        The effects of fructose intake on serum uric acid vary among controlled dietary trials.
        J Nutr. 2012; 142: 916-923
        • Sievenpiper J.L.
        • Chiavaroli L.
        • de Souza R.J.
        • Mirrahimi A.
        • Cozma A.I.
        • Ha V.
        • et al.
        ‘Catalytic’ doses of fructose may benefit glycaemic control without harming cardiometabolic risk factors: a small meta-analysis of randomised controlled feeding trials.
        Br J Nutr. 2012; 108: 418-423
        • Sievenpiper J.L.
        • de Souza R.J.
        • Mirrahimi A.
        • Yu M.E.
        • Carleton A.J.
        • Beyene J.
        • et al.
        Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis.
        Ann Intern Med. 2012; 156: 291-304
        • Ha V.
        • Sievenpiper J.L.
        • de Souza R.J.
        • Chiavaroli L.
        • Wang D.D.
        • Cozma A.I.
        • et al.
        Effect of fructose on blood pressure: a systematic review and meta-analysis of controlled feeding trials.
        Hypertension. 2012; 59: 787-795
        • Sievenpiper J.L.
        • Carleton A.J.
        • Chatha S.
        • Jiang H.Y.
        • de Souza R.J.
        • Beyene J.
        • et al.
        Heterogeneous effects of fructose on blood lipids in individuals with type 2 diabetes: systematic review and meta-analysis of experimental trials in humans.
        Diabetes Care. 2009; 32: 1930-1937
        • Sánchez-Lozada L.G.
        • Mu W.
        • Roncal C.
        • Sautin Y.Y.
        • Abdelmalek M.
        • Reungjui S.
        • et al.
        Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver.
        Eur J Nutr. 2010; 49: 1-9
        • Nagai Y.
        • Yonemitsu S.
        • Erion D.M.
        • Iwasaki T.
        • Stark R.
        • Weismann D.
        • et al.
        The role of peroxisome proliferator activated receptor gamma coactivator-1 beta in the pathogenesis of fructose induced insulin resistance.
        Cell Metab. 2009; 9: 252-264
        • Ouyang X.
        • Cirillo P.
        • Sautin Y.
        • McCall S.
        • Bruchette J.L.
        • Diehl A.M.
        • et al.
        Fructose consumption as a risk factor for non-alcoholic fatty liver disease.
        J Hepatol. 2008; 48: 993-999
        • Song M.
        • Schuschke D.A.
        • Zhou Z.
        • Chen T.
        • Pierce Jr., W.M.
        • Wang R.
        • et al.
        High fructose feeding induces copper deficiency in Sprague–Dawley rats: a novel mechanism for obesity related fatty liver.
        J Hepatol. 2012; 56: 433-440
        • Bergheim I.
        • Weber S.
        • Vos M.
        • Krämer S.
        • Volynets V.
        • Kaserouni S.
        • et al.
        Antibiotics protect against fructoseinduced hepatic lipid accumulation in mice: role of endotoxin.
        J Hepatol. 2008; 48: 983-992
        • Spruss A.
        • Kanuri G.
        • Wagnerberger S.
        • Haub S.
        • Bischoff S.C.
        • Bergheim I.
        Tolllike receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.
        Hepatology. 2009; 50: 1094-1104
        • Yilmaz Y.
        Review article: fructose in non-alcoholic fatty liver disease.
        Aliment Pharmacol Ther. 2012; 35: 1135-1144
        • Cheung O.
        • Kapoor A.
        • Puri P.
        • Sistrun S.
        • Luketic V.A.
        • Sargeant C.C.
        • et al.
        The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome.
        Hepatology. 2007; 46: 1091-1100
        • Yang Y.J.
        • Kim M.K.
        • Hwang S.H.
        • Ahn Y.
        • Shim J.E.
        • Kim D.H.
        Relative validities of 3-day food records and the food frequency questionnaire.
        Nutr Res Pract. 2010; 4: 142-148
      2. US Department of Agriculture. Economic Research Service. Sugar and Sweeteners Yearbook Tables. Available at: http://www.ers.usda.gov/topics/crops/sugar-sweeteners.aspx [accessed 19.11.12].

        • Leclercq C.
        • Arcella D.
        • Piccinelli R.
        • Sette S.
        • Le Donne C.
        • Turrini A.
        The Italian national food consumption survey INRAN.SCAI 2005–06: main results in terms of food consumption.
        Public Health Nutr. 2009; 12: 2504-2532